Phase IIb randomized, blinded, controlled trial evaluating neoadjuvant PD-1 blockade combined with A2B5<sup>+</sup> glioma stem-like cell lysate-loaded DC vaccine in recurrent glioblastoma (IDH1/2 -).Yu Yao, Liangfu Zhou, Chenwei Li et al.|Journal of Clinical Oncology|2024Cited by 2
CTIM-07. PHASE IIB RANDOMIZED, BLINDED, CONTROLLED TRIAL EVALUATING NEOADJUVANT PD-1 BLOCKADE COMBINED WITH A2B5+ GLIOMA STEM-LIKE CELL LYSATE-LOADED DCV IN RECURRENT GLIOBLASTOMA (IDH1/2 -)- TRAIL IN PROGRESSYu Yao, Liangfu Zhou, Xiaoming Huang et al.|Neuro-Oncology|2023Cited by 0